AU Stock MarketDetailed Quotes
BDX BCAL Diagnostics Ltd
- 0.125
- 0.0000.00%
20min DelayMarket Closed Jun 7 15:56 AET
31.54MMarket Cap-5208P/E (Static)
0.125High0.120Low1.44MVolume0.125Open0.125Pre Close176.07KTurnover0.21052wk High1.49%Turnover Ratio252.29MShares0.07052wk Low-0.023EPS TTM12.09MFloat Cap0.275Historical HighLossP/E (Static)96.70MShs Float0.051Historical Low-0.024EPS LYR4.00%Amplitude--Dividend TTM5.21P/B1Lot Size--Div YieldTTM
BCAL Diagnostics Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
|---|---|---|
| Operating cash flow (direct method) | ||
| Cash income from operating activities | 237.61%976.16K | 289.14K |
| Other cash income from operating activities | 237.61%976.16K | --289.14K |
| Cash paid | -101.16%-7.07M | -3.51M |
| Payments to suppliers for goods and services | -101.16%-7.07M | ---3.51M |
| Direct interest paid | ---16.31K | ---- |
| Direct interest received | 975.77%61.04K | --5.67K |
| Operating cash flow | -87.87%-6.05M | ---3.22M |
| Investing cash flow | ||
| Cash flow from continuing investing activities | 190.36%3.64M | -4.03M |
| Net PPE purchase and sale | -1,307.00%-362.47K | ---25.76K |
| Net intangibles purchas and sale | 200.00%4M | ---4M |
| Cash from discontinued investing activities | ||
| Investing cash flow | 190.36%3.64M | ---4.03M |
| Financing cash flow | ||
| Cash flow from continuing financing activities | -99.86%13.24K | 9.41M |
| Net common stock issuance | -99.47%50K | --9.41M |
| Net other financing activities | ---36.76K | ---- |
| Cash from discontinued financing activities | ||
| Financing cash flow | -99.86%13.24K | --9.41M |
| Net cash flow | ||
| Beginning cash position | 63.50%5.57M | --3.41M |
| Current changes in cash | -210.79%-2.4M | --2.16M |
| End cash Position | -43.03%3.17M | --5.57M |
| Free cash from | 16.52%-6.05M | ---7.25M |
| Accounting Standards | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg